Q4 2013 13F Holders as of 31 Dec 2013
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
79,348,837
-
Share change
-
-1,652,774
-
Total reported value
-
$263,371,903
-
Put/Call ratio
-
9.8%
-
Price per share
-
$3.32
-
Number of holders
-
94
-
Value change
-
-$5,501,426
-
Number of sells
-
2
Institutional Holders of ACHILLION PHARMACEUTICALS IN - COM (ACHN) as of Q4 2013
As of 31 Dec 2013,
ACHILLION PHARMACEUTICALS IN - COM (ACHN) was held by
94 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
79,348,837 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, LLC, QVT Financial LP, State Street Corp, VANGUARD GROUP INC, Capital World Investors, BlackRock Fund Advisors, BlackRock Institutional Trust Company, N.A., STATE OF WISCONSIN INVESTMENT BOARD, GOLDMAN SACHS GROUP INC, and BB Biotech AG.
This page lists
94
institutional shareholders reporting positions in this security
for the Q4 2013 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.